Signal detail

News insight

Source-backed analysis, the reasoning behind the signal, and its market context.

STIMBullishEarningsShort Term

High materiality9/10

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

StockNews.AIAug 11, 7:50 AM EDT1 source

Trading thesisImportance 9/10

Bullish: margin expansion and profitability trajectory support STIM gains over 6–12 months, contingent on sustained Greenbrook growth and cash-flow improvement.

AI summary

What happened and why it matters

Neuronetics reported Q2 2026 revenue of $41.6 million, up 9.1% YoY, with Greenbrook revenue at $26.9 million, up 16.8%. Adjusted EBITDA turned positive to $0.3 million, while net loss narrowed to $3.4 million. The company reaffirmed 2026 guidance and highlighted leadership changes and a stronger go-to-market, signaling progress toward profitability and reduced cash burn in the second half.

Q2 beat on revenue and narrowing losses supports a positive near-term stock reaction.
Greenbrook growth accelerates; Greenbrook revenue up 16.8% YoY.
Adj. EBITDA positive for Q2; quarterly cash burn reduced.
Guidance unchanged; execution risk remains given net cash outflows.

Sentiment rationale

The company posted a positive swing in profitability metrics (Adjusted EBITDA) and improving gross margins (51.1%), along with revenue growth and leadership additions. These factors support a more favorable near-term view, especially if Greenbrook continues to scale and cash burn remains on a downward trend. Historically, similar quarterly improvements in margin and cash flow for small-cap healthcare tech names have driven short- to medium-term upside, barring reversals in reimbursement dynamics or slower-than-expected clinic growth.

Key facts

01
Q2 2026 revenue was $41.6M, up 9.1% YoY.
02
Greenbrook revenue was $26.9M, up 16.8% YoY.
03
Adjusted EBITDA turned positive at $0.3M; net loss $3.4M vs $10.1M prior.
04
Leadership changes: Nir Naor named CFO; Cory Anderson; Rob Greene in Sales.
05
Full-year 2026 guidance unchanged: revenue 160–164M; gross margin 48–50%; negative cash flow.

Earnings

Earnings. The release combines quarterly results, margin dynamics, leadership changes, and 2026 guidance, making it a typical earnings-driven update with an execution-related growth narrative.